medigraphic.com

2012, Número 3

<< Anterior Siguiente >>

Rev Mex Anest 2012; 35 (3)


Anestesia y complicaciones hemodinámicas en el cierre percutáneo de la comunicación interauricular en el Centro Médico ISSEMyM

Gómez-Ríos N, Rodríguez-Ortega MF, Hernández-Mercado MA, Palma-Mercado J, Arreola-López G, Victoria-Campos JL, Rojas-Pérez E

Idioma: Español
Referencias bibliográficas: 66
Paginas: 174-180
Archivo PDF: 316.01 Kb.


RESUMEN

Objetivo: Reportar nuestro protocolo anestésico, así como las complicaciones hemodinámicas presentadas durante la colocación de los dispositivos percutáneos para cierre de defectos septales auriculares. Métodos: Entre enero de 2008 y diciembre de 2010 se realizó la revisión de 30 expedientes clínicos de los pacientes con diagnóstico de comunicación interauricular y que fueron candidatos a cierre percutáneo analizando las siguientes variables: edad, género, características del defecto septal, protocolo anestésico, estudio ecocardiográfico, tipo de dispositivo y complicaciones hemodinámicas. Resultados: Se estudiaron 30 pacientes, en su mayoría del género femenino; con edad promedio de 41.4 años; tipo ostium secundum en 24 y foramen oval en 6; defecto promedio de 18.3 mm y 5.26 mm, anestesia general en el 100% de los casos, presión pulmonar promedio de 51.41 mmHg y 39.66 mmHg, Qp: Qs de 2.4:1 y 1.6:1, en todos los casos se realizó ecocardiograma transtorácico previo al procedimiento y transesofágico durante la colocación del dispositivo, se utilizó dispositivo tipo Helex® en 6 y Occlutech Figulla® en 24; un paciente presentó migración del dispositivo y se convirtió a cirugía que cursó con adecuada evolución postprocedimiento, con un seguimiento a 16 meses. Conclusión: La técnica anestésica idónea en cada paciente debe garantizar la estabilidad hemodinámica y con ello, lograr la adecuada colocación del dispositivo por el equipo médico-quirúrgico.


REFERENCIAS (EN ESTE ARTÍCULO)

  1. Warnes CA, Williams RG, Bashore TM, Child JS, Connolly HM, Dearani JA. ACC/AHA 2008 Guidelines for the management of adults with congenital heart disease. J Am Coll Cardiol 2008;52:1-121.

  2. Campbell M. Natural history of atrial septal defect. Br Heart J 1970;32:820-5.

  3. Attie F, Rosas M, Granados N, Buendía A, Zabal C, Calderón J. Anatomical closure for atrial septal defect in patients aged over 40 years. A randomized clinical trials. J Am Coll Cardiol 2001; 38:2035-42.

  4. Bermúdez-Cañete R, Abelleira C, Sánchez I. Cardiopatías congénitas del adulto: procedimientos terapéuticos percutáneos. Rev Esp Cardiol 2009;9:75-97.

  5. Fuentes-García V, Gerardo-de la Cruz S, Alarcón-Almanza JM, Moyao-García D, Nava-Ocampo AA. Manejo anestésico en niños sometidos al cierre de la comunicación interauricular con el dispositivo Amplatzer. Rev Mex Pediatr 2005;72:292-97.

  6. Molina-Méndez FJ. Laboratorio de cateterización cardíaca y el anestesiólogo. Rev Mex Anest 2007;30:s208-s212.

  7. Cannesson M, Earing MG, Collange V, Kersten JR. Anesthesia for noncardiac surgery in adults with congenital heart disease. Anesthesiology 2009;111:432-40.

  8. Jones TK, Latson LA, Zahn E, Fleishman CE, Jacobson J, Vincent R, et al. Results of the US multincenter pivotal study of HELEX septal occluder for percutaneous closure of secundum atrial defects. J Am Coll Cardiol 2007;49:2215-21.

  9. Hickey PR, Wessel DL, Streitz SL, Fox ML, Kern FH, Bridges ND, et al. Transcatheter closure of atrial septal defects: hemodynamic complications and anesthetic management. Anesth Analg 1992;74:44-50.

  10. Chessa M, Carrozza M, Butera G Negura D, Piazza l, Giamberti A. The impact of interventional cardiology for the management of adults with congenital heart defects. Catheter Cardiovasc Interv 2006;67:258-64.

  11. Brickner ME, Hillis D, Lange RA. Congenital heart disease in adults. N Engl J Med 2000;242:256-63.

  12. Dimopoulos K, Peset A, Gatzoulis MA. Evaluating operability in adults with congenital heart disease and the role of pretreatment with targeted pulmonary arterial hypertension therapy. Int J Cardiol 2008;129:163-71.

  13. Amin Z. Transcatheter closure of secundum atrial septal defects. Catheter Cardiovasc Interv 2006;68:778-87.

  14. Suárez de Lezo J, Medina A, Pan M, Romero M, Segura J, Pavlovic D, et al. Transcatheter occlusion of complex atrial septal defects. Cathet Cardiovasc Intervent 2000;51:33-41.

  15. Rigby M. The era of transcatheter closure of atrial septal defects. Heart 1999;81:227-8.

  16. Suarez de Lezo J, Medina A, Romero M, Pan M, Segura J, Caballero E, et al. Effectiveness of percutaneous device occlusion for atrial septal defect in adult patients with pulmonary hypertension. Am Heart J. 2002;144;877-80.

  17. Suárez de Lezo J, Medina A, Pan M, Romero M, Segura J, Pavlovic DJ, et al. Transcatheter occlusion of complex atrial septal defects. Cathet Cardiovasc Intervent 2000;51:33-41.

  18. Rodríguez M, Suárez de Lezo J, Pan M, Romero M, Segura J, Pavlovic DJ y cols. Cierre percutáneo de comunicaciones interauriculares grandes. Rev Esp Cardiol 2003;56:888-93.

  19. Cao QL, Radtke W, Berger F, Zhu W, Hijazi ZM. Transcatheter closure of multiple atrial septal defects. Initial results and value of two and three dimensional transesophageal echocardiography. Eur Heart J 2000;21:941-7.

  20. Ilkay E, Kacmaz F, Özeke Ö, Turan RS, Firat S, Pampal K, et al. The efficiency and safety of percutaneous closure of secundum atrial septal defects with the Occlutech Figulla device: initial clinical experience. Türk Kardiyol Derm Ars 2010;38:189-193.

  21. Pac A, Polat TB, Cetin I, Oflaz MB, Balli S. Figulla ASD occluder versus Amplatzer septal occluder: A comparative study on validation of novel device for percutaneous closure of atrial septal defects. J Interven Cardiol 2009;1:1-7.

  22. Karamlou T, Diggs BS, Ungerleider RM, McCrindle BW, Welke KF. The rush to atrial septal defect closure: Is the introduction of percutaneous closure driving utilization? Ann Thorac Surg 2008;86:1584-91.

  23. Krizanic F, Sievert H, Pfeiffer D, KonorzaT, Ferrari M, Hijazi Z, et al. The Occlutech Figulla PFO and ASD occluder: A new nitinol wire mesh device for closure of atrial septal defects. J Invasive Cardiol 2010;22:182-87.

  24. Giardini A, Donti A, Formigari R, Specchia S, Prandstraller D, Bronzetti G. Determinants of cardiopulmonary functional improvement after transcatheter atrial septal defect closure in asymptomatic adults. J Am Coll Cardiol 2004;43:1886-91.

  25. Bermúdez-Cañete R, Velasco Bayón JM, Herráiz JI, Mullins CE, Acerete F, Díaz García P y cols. Cateterismo terapéutico: cierre percutáneo del ductus y comunicación interauricular. Rev Esp Cardiol 1992;45:42-50.

  26. Rigatelli G, Cardaioli P, Giordan M, Dell’Avvocata F, Braggion G, Piergentili C. Transcatheter intracardiac echocardiography- assisted closure of interatrial shunts: complications and midterm follow-up. Echocardiography 2009;26:196-202.

  27. Pan M, Suárez de Lezo J, Medina A, Romero M, Segura J, Mesa D. Tratamiento percutáneo de los aneurismas del septo interauricular. Rev Esp Cardiol 2005;58:222-6.

  28. Rao PS, Langhough R. Relationship of echocardiographic, shunt flow, and angiographic size to the stretched diameter of the atrial septal defect. Am Heart J 1991;122:505-8.

  29. Hernández F, García-Tejada J, Velázquez M, Albarrán A, Andreu J, Tascón J. Ecocardiografía intracardíaca en el cierre percutáneo de defectos del septo interauricular en adultos. Rev Esp Cardiol 2008;61:465-70.

  30. Amin Z. Transcatheter closure of secundum atrial septal defects. Catheter Cardiovasc Interv 2006;68:778-87.

  31. Hijazi Z, Wang Z, Cao Q, Koening P, Waight D, Lang R. Transcatheter closure of atrial septal defects and patent foramen ovale under intracardiac echocardiographic guidance: feasibility and comparison with transesophageal echocardiography. Catheter Cardiovasc Interv 2001;52:194-9.

  32. Rigateli G, Cardaioli P, Braggion G, Aggio S, Giordan M, Magro B, et al. Transesophageal echocardiography and intracardiac echocardiography differently predict potential technical challenges or failures of interatrial shunts catheter-based closure. J Interven Cardiol 2007;20:77-81.

  33. Pearson AC, Nagelhout D, Castello R, Gómez CR, Labovitz AJ. Atrial septal aneurysm and stroke: a transesophageal echocardiographic study. J Am Coll Cardiol 1991;18:1223-9.

  34. Dalvi BV, Pinto RJ, Gupta A. New technique for device closure of large atrial septal defects. Catheter Cardiovasc Interv 2005;64:102-7.

  35. Berdat PA, Chatterjee T, Pfammatter JP, Windecker S, Meier B, Carrel T. Surgical management of complications after transcatheter closure of an atrial septal defect or patent foramen ovale. T J Thorac Cardiovasc Surg 2000;120:1034-9.

  36. Chessa M, Carminati M, Butera G, Bini RM, Drago M, Rosti L. Early and late complications associated with transcatheter occlusion of secundum atrial septal defect. J Am Coll Cardiol 2002;39:1061-5.

  37. Konstantinides S, Geibel A, Olschewski M, Gornandt L, Roskamm H, Spillner G, et al. A comparison of surgical and medical therapy for atrial septal defect in adults. N Engl J Med 1995;333:469-73.

  38. Du ZD, Hijazi Z, Kleinman C, Silverman N, Larntz K, for the Amplatzer investigators. Comparison between transcatheter and surgical closure of secundum atrial septal defect in children and adults. J Am Coll Cardiol 2002;39:1836-44.

  39. Dave KS, Pakrashi BC, Wooler GH, Ionescu MI. Atrial septal defect in adults: clinical and hemodynamic results of surgery. Am J Cardiol 1978;31:7-13.

  40. Gatzoulis MA, Freeman MA, Samuel CS, Web GD, Harris L. Atrial arrhythmia after surgical closure of atrial septal defects in adults. N Engl J Med 1999;340:839-46.

  41. Zabala AJL, García E, Zunzunegui Martínez JL, Maroto Álvaro E, Maroto MC, Greco R, et al. Cierre percutáneo de la comunicación interauricular: resultados a medio plazo. Rev Esp Cardiol 2000;53:21-6.

  42. Hopkins WE, Ochoa LL, Richardson GW, Trulock EP. Comparison of the hemodynamics and survival of adults with severe primary pulmonary hypertension or Eisenmenger syndrome. J Heart Lung Transplant 1996;15:100-5.

  43. Balint OH, Samman A, Haberer K, Tobe L, McLaughlin P, Siu SC, et al. Outcomes in patients with pulmonary hypertension undergoing percutaneous atrial septal defect closure. Heart 2008;94:1189-93.

  44. Mashman WE, King SB, Jacobs WC, Ballard WL. Two cases of late embolization of Amplatzer septal occluder devices to the pulmonary artery following closure of secundum atrial defects. Catheter Cardiovasc Interv 2005;65:588-92.

  45. Chessa M, Carminati M, Butera G, Bini RM, Drago M, Rosti L, et al. Early and late complications associated with transcatheter occlusion of secundum atrial septal defect. J Am Coll Cardiol 2002;39:1061-5.

  46. Krumsdorf U, Ostermayer S, Billinger K, Trepels T. Incidence and clinical course of thrombus formation on atrial septal defect and patient foramen ovale closure devices in 1,000 consecutive patients. J Am Coll Cardiol 2004;21:302-9.

  47. Ourania P, Sridhar S, Wasnick J, Gold JP. Late cardiac perforation following transcatheter atrial septal defect closure. Ann Thorac Surg 2004;77:1435-7.

  48. Trepels T, Zeplin H, Sievert H, Billinger K. Cardiac perforation following transcatheter PFO closure. Catheter Cardiovasc Interv 2003;58:111-3.

  49. Mesa D, Franco M, Suárez de Lezo J, Muñoz J, Rus C, Delgado M y cols. Prevalencia de foramen oval permeable en pacientes jóvenes con accidente isquémico cerebral de causa desconocida. Rev Esp Cardiol 2003;56:662-8.

  50. Overell JR, Bone I, Lees KR. Interatrial septal abnormalities and stroke: a meta-analysis of case-control studies. Neurology 2000;55:1172-9.

  51. Hara H, Virmani R, Ladich E, Mackey-Bojack S, Titus J, Reisman M, et al. Patent foramen ovale: current pathology, pathophysiology and clinical status. J Am Coll Cardiol 2005;46:1768-76.

  52. De Castro S, Cartoni D, Fiorelli M, Rasura M, Anzini A, Zanette EM, et al. Morphological and functional characteristics of patent foramen ovale and their embolic implications. Stroke 2000;31:2407-13.

  53. Nedeltchev K, Arnold M, Wahl A, Sturzenegger M, Vella EE, Windecker S, et al. Outcome of patients with cryptogenic stroke and patent foramen ovale. J Neurol Neurosurg Psychiatry 2002;72:347-50.

  54. Bialkowski J, Kusa J, Szkutnik M, Kalarus Z, Banaszak P, Bermudez-Canete R y cols. Cierre percutáneo de la comunicación interauricular. Resultados a corto y mediano plazo. Rev Esp Cardiol 2003;56:383-8.

  55. Schwerzmann M, Windecker S, Wahl A, Mehta H, Nedeltchew K, Mattle H, et al. Percutaneous closure of patent foramen ovale: impact of device design on safety and efficacy. Heart 2004;90:186-90.

  56. Khodaverdian RA, Jonez KW. Metal allergy to Amplatzer occluder device presented as severe bronchospasm. Ann Thorac Surg 2009;88:2021-2.

  57. Preventza O, Sampath-Kumar S, Wasnick J, Gold JP. Late perforation following transcatheter atrial septal defect closure. Ann Thorac Surg 2004;77:1435-7.

  58. Cecconi M, Quarti A, Bianchini F, Bucari S, Constantini C, Giovagnoni A, et al. Late cardiac perforation after transcatheter closure of patent foramen ovale. Ann Thorac Surg 2006;81:29-30.

  59. Scholtz W, Jategaonkar S, Faber L, Horstkotte D. Unusual complication with transcatheter closure o fan atrial septal defect prevented by adequate Imaging. Circulation 2008;117:181-183.

  60. Ortega TJR, Suárez de Lezo HTJ, García QA, Melián NF, Rodríguez DR, Medina FAA. Cierre percutáneo de foramen oval permeable en el síndrome platipnea-ortodesoxia. Rev Esp Cardiol 2006;59:78-81.

  61. Seward JB, Hayes DL, Smith HC, Williams DE, Rosenow EC 3rd, Reeder GS, et al. Platypnea-orthodeoxia: clinical profile diagnostic workup, management and report of seven cases. Mayo Clin Proc 1994;59:221-31.

  62. Sorrentino M, Resnekov L. Patent foramen ovale associated with platypnea and orthodeoxia. Chest. 1991; 100:1157-8.

  63. Timmermans C, Frans E, Herregods C, Decramer M, Daenen W, DeGeest H. Platypnea-orthodeoxia syndrome: a report of two cases. Acta Cardiol. 1993;6:583-90.

  64. Guerin P, Lambert V, Godart F, Legendre A, Petit J, Bourlon F, et al. Transcatheter closure of patent foramen ovale in patients with platypnea-orthodeoxia: results of a Multicentric French Registry. Cardiovasc Intervent Radiol 2005;28:164-8.

  65. Khairy P, O’Donnell CP, Landzberg MJ. Transcatheter closure versus medical therapy of patent foramen ovale and presumed paradoxical thromboembolism: a systematic review. Ann Intern Med 2003;139:753-60.

  66. Mas JL, Arquizan C, Lamy C, Zuber M, Cabanes L, Derumeaux G, et al. Recurrent cerebrovascular events associated with patent foramen ovale, atrial septal aneurysm, or both. N Engl J Med 2001;345:1740-6.




2020     |     www.medigraphic.com